loadpatents
Patent applications and USPTO patent grants for ARNOLD; Lee D..The latest application filed is for "pharmaceutical compositions for the treatment of hbv".
Patent | Date |
---|---|
Pharmaceutical Compositions For The Treatment Of Hbv App 20220241208 - ARNOLD; Lee D. ;   et al. | 2022-08-04 |
Inhibitors of cyclin-dependent kinases Grant 11,390,618 - Kanouni , et al. July 19, 2 | 2022-07-19 |
Inhibitors of cyclin-dependent kinases Grant 11,358,958 - Kanouni , et al. June 14, 2 | 2022-06-14 |
Inhibitors of fibroblast growth factor receptor kinases Grant 11,345,681 - Kaldor , et al. May 31, 2 | 2022-05-31 |
Inhibitors Of Cysteine Proteases And Methods Of Use Thereof App 20220162194 - Arnold; Lee D. ;   et al. | 2022-05-26 |
Inhibitors of cysteine proteases and methods of use thereof Grant 11,312,704 - Arnold , et al. April 26, 2 | 2022-04-26 |
Hepatitis B Core Protein Modulators App 20220023311 - Turner; William W. ;   et al. | 2022-01-27 |
Process For Making Hepatitis B Core Protein Modulators App 20210380577 - Li; Leping ;   et al. | 2021-12-09 |
Inhibitors Of Cysteine Proteases And Methods Of Use Thereof App 20210355111 - Arnold; Lee D. ;   et al. | 2021-11-18 |
Inhibitors of cysteine proteases and methods of use thereof Grant 11,174,231 - Arnold , et al. November 16, 2 | 2021-11-16 |
Inhibitors of cysteine proteases and methods of use thereof Grant 11,124,497 - Arnold , et al. September 21, 2 | 2021-09-21 |
Cyclic sulfamide compounds and methods of using same Grant 11,078,170 - Turner, Jr. , et al. August 3, 2 | 2021-08-03 |
Process for making Hepatitis B core protein modulators Grant 11,040,965 - Li , et al. June 22, 2 | 2021-06-22 |
Process for making Hepatitis B core protein modulators Grant 11,008,315 - Li , et al. May 18, 2 | 2021-05-18 |
Inhibitors Of Cyclin-dependent Kinases App 20210130340 - KANOUNI; Toufike ;   et al. | 2021-05-06 |
Hepatitis B core protein modulators Grant 10,987,360 - Turner, Jr. , et al. April 27, 2 | 2021-04-27 |
Hepatitis B core protein modulators Grant 10,968,211 - Turner, Jr. , et al. April 6, 2 | 2021-04-06 |
Inhibitors of cyclin-dependent kinases Grant 10,894,788 - Kanouni , et al. January 19, 2 | 2021-01-19 |
Cyclic Sulfamide Compounds And Methods Of Using Same App 20200157070 - Turner, JR.; William W. ;   et al. | 2020-05-21 |
Hepatitis B Core Protein Modulators App 20200131168 - Turner, JR.; William W. ;   et al. | 2020-04-30 |
Inhibitors Of Cyclin-dependent Kinases App 20200024266 - KANOUNI; Toufike ;   et al. | 2020-01-23 |
Process For Making Hepatitis B Core Protein Modulators App 20200002325 - Li; Leping ;   et al. | 2020-01-02 |
Hepatitis B Core Protein Modulators App 20190255067 - Turner, JR.; William W. ;   et al. | 2019-08-22 |
Fused bicyclic mTOR inhibitors Grant 8,796,455 - Chen , et al. August 5, 2 | 2014-08-05 |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,735,405 - Arnold , et al. May 27, 2 | 2014-05-27 |
Combination cancer therapy Grant 8,575,164 - Arnold , et al. November 5, 2 | 2013-11-05 |
FUSED BICYCLIC mTOR INHIBITORS App 20130165651 - Chen; Xin ;   et al. | 2013-06-27 |
Fused bicyclic motor inhibitors Grant 8,314,111 - Chen , et al. November 20, 2 | 2012-11-20 |
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20120196847 - Arnold; Lee D. ;   et al. | 2012-08-02 |
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20120077979 - Arnold; Lee D. ;   et al. | 2012-03-29 |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,101,613 - Arnold , et al. January 24, 2 | 2012-01-24 |
Fused Bicyclic mTOR Inhibitors App 20110218183 - Chen; Xin ;   et al. | 2011-09-08 |
FUSED BICYCLIC mTOR INHIBITORS App 20110190496 - Chen; Xin ;   et al. | 2011-08-04 |
Fused bicyclic mTOR inhibitors Grant 7,943,767 - Chen , et al. May 17, 2 | 2011-05-17 |
Fused bicyclic mTor inhibitors Grant 7,923,555 - Chen , et al. April 12, 2 | 2011-04-12 |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 7,820,662 - Arnold , et al. October 26, 2 | 2010-10-26 |
FUSED BICYCLIC mTOR INHIBITORS App 20100099679 - Chen; Xin ;   et al. | 2010-04-22 |
Fused bicyclic mTOR inhibitors Grant 7,700,594 - Chen , et al. April 20, 2 | 2010-04-20 |
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20090325928 - Arnold; Lee D. ;   et al. | 2009-12-31 |
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors Grant 7,560,552 - Michaelides , et al. July 14, 2 | 2009-07-14 |
Fused Bicyclic mTor Inhibitors App 20090163468 - Chen; Xin ;   et al. | 2009-06-25 |
6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 7,534,797 - Arnold , et al. May 19, 2 | 2009-05-19 |
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20090118499 - Arnold; Lee D. ;   et al. | 2009-05-07 |
Tricyclic pyrazole kinase inhibitors Grant 7,468,371 - Arnold , et al. December 23, 2 | 2008-12-23 |
Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents App 20080299113 - Arnold; Lee D. ;   et al. | 2008-12-04 |
Combination cancer therapy App 20080267957 - Arnold; Lee D. ;   et al. | 2008-10-30 |
Method of identifying inhibitors of Tie-2 Grant 7,369,946 - Bump , et al. May 6, 2 | 2008-05-06 |
Pyrazolopyrimidines as therapeutic agents Grant 7,332,497 - Hirst , et al. February 19, 2 | 2008-02-19 |
Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents App 20080014200 - Arnold; Lee D. ;   et al. | 2008-01-17 |
N-phenylbenzotriazolyl c-kit inhibitors App 20070232669 - Crew; Andrew Philip ;   et al. | 2007-10-04 |
Fused heterobicyclic kinase inhibitors App 20070208053 - Arnold; Lee D. ;   et al. | 2007-09-06 |
Fused bicyclic mTOR inhibitors App 20070112005 - Chen; Xin ;   et al. | 2007-05-17 |
Thiopyrimidine and isothiazolopyrimidine Kinase Inhibitors App 20060276490 - Michaelides; Michael R. ;   et al. | 2006-12-07 |
6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors App 20060235031 - Arnold; Lee D. ;   et al. | 2006-10-19 |
Benzothiazole derivatives Grant 7,091,227 - Scott , et al. August 15, 2 | 2006-08-15 |
Aminobenzoxazoles as therapeutic agents App 20060025383 - Wishart; Neil ;   et al. | 2006-02-02 |
Tricyclic pyrazole kinase inhibitors App 20060014816 - Arnold; Lee D. ;   et al. | 2006-01-19 |
Pyrazolopyrimidines as therapeutic agents Grant 6,921,763 - Hirst , et al. July 26, 2 | 2005-07-26 |
Pyrrolopyrimidines as therapeutic agents Grant 6,713,474 - Hirst , et al. March 30, 2 | 2004-03-30 |
Pyrazolopyrimidines as therapeutic agents App 20040006083 - Hirst, Gavin C. ;   et al. | 2004-01-08 |
Pyrazolopyrimidines as therapeutic agents Grant 6,660,744 - Hirst , et al. December 9, 2 | 2003-12-09 |
Kinase inhibitors App 20030225098 - Hirst, Gavin C. ;   et al. | 2003-12-04 |
Kinase inhibitors App 20030199525 - Hirst, Gavin C. ;   et al. | 2003-10-23 |
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors App 20030181468 - Michaelides, Michael R. ;   et al. | 2003-09-25 |
Pyrrolopyrimidines as therapeutic agents App 20030153752 - Hirst, Gavin C. ;   et al. | 2003-08-14 |
Benzothiazole derivatives App 20030153568 - Cusack, Kevin P. ;   et al. | 2003-08-14 |
Method of identifying inhibitors of Tie-2 App 20030082622 - Bump, Nancy J. ;   et al. | 2003-05-01 |
Pyrazolopyrimidines as therapeutic agents App 20020156081 - Hirst, Gavin C. ;   et al. | 2002-10-24 |
Tricyclic pyrazole derivatives Grant 6,462,036 - Doyle , et al. October 8, 2 | 2002-10-08 |
4-aminoquinazolone derivatives Grant 6,225,318 - Sobolov-Jaynes , et al. May 1, 2 | 2001-05-01 |
4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents Grant 5,736,534 - Arnold April 7, 1 | 1998-04-07 |
SEC | 0001613258 | Arnold Lee D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.